A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 179 participants.
Also called NCT04663282
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 179 participants
- Registry
-
NCT04663282
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Australia, China
- Registry status
- Completed
Technical summary
Registry record NCT04663282. Randomized; no masking; primary purpose treatment. Start 2021-02-04 (actual); primary completion 2022-05-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- INS068 injection
- Intervention (Drug)
- Insulin Degludec
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct04663282- Content hash
987bbd8b40e142adad36bebff7e89730cb9da326edcdc77651912b2e3af29291